{
    "title": "Amylyx's ALS drug would not be cost effective if priced around $170,000- ICER",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10915289/Amylyxs-ALS-drug-cost-effective-priced-170-000-ICER.html",
    "date": "2022-06-14",
    "keywords": [
        "drug",
        "disease",
        "cost",
        "study",
        "leo",
        "watchdog",
        "icer",
        "price",
        "production",
        "june",
        "sclerosis",
        "tuesday",
        "institute",
        "review",
        "draft",
        "report",
        "pricing",
        "amylyx",
        "panel",
        "food",
        "administration",
        "approval",
        "effectiveness",
        "fda",
        "information",
        "company",
        "deadline",
        "lou",
        "nerve",
        "brain",
        "cord",
        "function",
        "disability",
        "death",
        "cause",
        "care",
        "riluzole",
        "mitsubishi",
        "tanabe",
        "pharmas",
        "progression",
        "acquisition",
        "suspension",
        "radicava",
        "albrioza",
        "monday",
        "health",
        "canada",
        "world",
        "midstage",
        "latestage",
        "reporting",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}